Evidence map›Paper›PMID 36140680›Full record

ArticleGenes2022

Clinical and Genetic Characteristics of Multiple Epiphyseal Dysplasia Type 4.

Tatiana Markova, Vladimir Kenis, Evgenii Melchenko, Aynur Alieva, Tatiana Nagornova, Anna Orlova, Natalya Ogorodova, Olga Shchagina, Alexander Polyakov, Elena Dadali and 1 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Melatonin amelioratesGenes & diseases · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Tatiana MarkovaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.ORCID 0000-0002-2672-6294
Vladimir KenisH. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery, Parkovaya 64-68, 196603 Saint Petersburg, Russia.
Evgenii MelchenkoH. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery, Parkovaya 64-68, 196603 Saint Petersburg, Russia.
Aynur AlievaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Tatiana NagornovaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Anna OrlovaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.ORCID 0000-0002-8831-1844
Natalya OgorodovaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Olga ShchaginaResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.ORCID 0000-0003-4905-1303
Alexander PolyakovResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Elena DadaliResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Sergey KutsevResearch Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.
Research Centre for Medical Genetics · RUThe Turner Scientific Research Institute for Children's Orthopedics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple epiphyseal dysplasias (MED) are a clinically and genetically heterogeneous group of skeletal dysplasias with a predominant lesion in the epiphyses of tubular bones. Variants in the SLC26A2 gene cause their autosomal recessive form (rMED or MED type 4). The accumulation of data regarding the genotype−phenotype correlation can help in the diagnosis and proper management of these patients. The aim of this study was to survey the clinical and genetic characteristics of 55 patients with MED type 4 caused by variants in the SLC26A2 gene. Diagnosis confirmation was carried out by radiography and custom panel sequencing consisting of 166 genes responsible for the development of hereditary skeletal pathology. This was followed by the validation of the identified variants using automated Sanger sequencing (for six patients) and the direct automatic Sanger sequencing of the coding sequence and the adjacent intron regions of the SLC26A2 gene for 49 patients. Based on the clinical and genetic analysis of our sample of patients, two main MED type 4 phenotypes with early and late clinical manifestations were identified. An early and more severe form of the disease was observed in patients with the c.835C > T variant (p.Arg279Trp), and the late and milder form of the disease was observed in patients with the c.1957T > A variant (p.Cys653Ser) in the homozygous or compound heterozygous state with c.26 + 2T > C. It was also shown that only three pathogenic variants were found in 95.3% of the alleles of Russian patients with MED type 4: c.1957T > A (p.Cys653Ser), c.835C > T (p.Arg279Trp), and c.26 + 2T > C; thus, it can be assumed that the primary analysis of these variants will contribute to the optimal molecular genetic diagnostics of MED type 4.

Indexed as

OsteochondrodysplasiasAnion Transport ProteinsHumansMutationPatellaSulfate TransportersAnion Transport ProteinsSLC26A2 protein, humanSulfate Transportersmultiple epiphyseal dysplasia type 4pathogenic variantsphenotype variabilitySLC26A2 gene

Identifiers

PMID36140680
PMCPMC9498659
OpenAlexW4293001443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.